Skip to main content

Table 3 Participant characteristics by message format condition

From: Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?

 

Verbal-only (n = 69)

Verbal and numerical combined (n = 72)

p

n

%

n

%

Gender

 Female

45

35

46

36

 

 Male

24

65

26

64

.869

Age at time of experiment, mean (SD)

57.72 (7.29)

 

56.83 (7.50)

 

.469

 < 50 years

8

11

13

18

 

 50–65 years

44

64

49

68

 

 > 65 years

17

25

10

14

.201

Education

 Primary school

8

11

12

17

 

 Secondary school

17

25

24

33

 

College/University

44

64

36

50

.255

Tumor

 Breast

22

32

22

31

 

 Hematologicala

13

19

8

12

 

 Urologicalb

10

15

13

18

 

 Gynecologicalc

7

10

10

14

 

 Head and neck

4

6

6

8

 

 Lung

2

3

4

5

 

 Skin

3

4

2

3

 

 Gastroenterologicald

3

4

2

3

 

 Othere

3

4

4

5

 

 Unknown

2

3

1

1

.912

Years since diagnosis, mean (SD)

6.48 (6.89)

 

5.01 (4.22)

 

.133

 0–5 years

43

62

52

72

 

 6–10 years

12

17

13

18

 

 11–15 years

8

12

5

7

 

 > 15 years

6

9

2

3

.318

Treatment(s)

     

 Surgery

48

70

48

67

.712

 Radiotherapy

40

58

35

49

.266

 Chemotherapy

40

58

37

51

.433

 Immunotherapy

13

19

11

15

.574

 Hormone therapy

18

26

24

33

.347

 Other

16

23

13

18

.451

Prior experience side effects

 Fatigue

55

80

49

68

.116

 Neuropathy

29

42

26

36

.471

 Smell and taste changes

30

44

27

38

.470

 Diarrhea

14

20

11

15

.436

 None of the above

7

10

9

13

.659

Subjective numeracy, mean (SD)f

4.51 (0.81)

 

4.64 (0.86)

 

.384

  1. aLymphoma, Leukemia, Multiple myeloma
  2. bProstate, bladder
  3. cUterus, cervix, ovary
  4. dEsophageal, anus, GIST, gall bladder, but excluding colorectal cancer
  5. eBrain, renal cell, undifferentiated pleomorphic sarcoma, neuroendocrine tumor
  6. fα = .82; SD standard deviation